SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSabien Tech. Regulatory News (SNT)

Share Price Information for Sabien Tech. (SNT)

Share Price is delayed by 15 minutes
Get Live Data
3.75    0.00 (0.00%)
Bid:
3.50
Ask:
4.00
Spread: 0.50 (14.286%)
Market Cap: £1.04m
SNT Live PriceLast checked at - London Stock Exchange

Intraday Sabien Tech. Share Chart

Trading Statement

8 Jul 2024 08:15

RNS Number : 4832V
Sabien Technology Group PLC
08 July 2024
 

8 July 2024

THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION FOR THE PURPOSES OF REGULATION 11 OF THE MARKET ABUSE (AMENDMENT) (EU EXIT) REGULATIONS 2019/310.

Sabien Technology Group plc

("Sabien" or the "Company" or the "Group")

Trading Update

Sabien (AIM: SNT), a leader in Green Aggregation Strategy, today provides a trading update ahead of the release of its final results for the year ended 30 June 2024.

During the financial year, Sabien has focused on expanding the M2G business, a CO2 mitigation technology for commercial and residential boilers, developing its Sales Agency opportunity with City Oil Field ("COF") and advancing b.grn group Limited ("b.grn"), a Special Purpose Vehicle in which the Company holds a 33.33% stake. This vehicle aims to commercialize COF plastic-to-oil technology.

M2G Business

The M2G Cloud Connect platform enables operators of commercial gas boilers to achieve gas bill savings and CO2 emission reductions of 10%-30%. This technology, when deployed at scale, significantly contributes to the UK's transition to a net-zero economy. M2G installations are quick, offering immediate savings and comprehensive plant analytics, with a typical payback period of less than 12 months.

A recent testimonial from a major Facilities Management partner highlighted the seamless installation and significant energy savings of approximately 30%, enhancing boiler efficiency and proving to be a sustainable, cost-effective solution.

For the year ended 30 June 2024, Sabien has secured orders totalling approximately £0.7m (£1.1m in 2023) and invoiced around £0.6m (£1.1m in 2023). It is notable that the 2023 results included a significant single order of £0.7m from a UK Government customer, whose repeat order for the 2024 financial year has been delayed due to wider political events but is anticipated to be confirmed later in 2024. Excluding this customer, M2G orders have grown by 54% compared to the previous financial year, demonstrating the effectiveness of our expansion strategy. Sabien also boosted its quoting activity with CBRE by 65% this year and in May 2024, signed a Preferred Supplier Agreement with CBRE GWS and CBRE Managed Services Ltd. Multiple blue chip end users were added to the M2G base via Sabien's partner network, all of whom are expected to contribute to future business growth.

Subject to final audit, Sabien expects to recognize revenue of approximately £0.7m for the year ended 30 June 2024 (£1.1m in 2023). As of the year-end, the Company had open orders of approximately £0.06m, deferred revenue of £0.11m, and recurring Cloud revenue of £0.08m, all expected to be recognized in the current financial year, total secured revenue at the start of the year of £0.25m.

During the year, the Board has implemented measures to streamline financial performance, including a 24% reduction in M2G headcount expenses, a 71% reduction in IOT and analytics infrastructure costs, and up to a 60% reduction in the cost of goods through reengineering efforts once the next generation M2G Cloud Connect launches this year. These savings will become evident in the next period.

COF / b.grn

In June 2024, Sabien extended its exclusive Sales Agency Agreement with COF for an additional five years, covering the UK and a region of the United States. This revised agreement includes an increased sales agency fee of up to $1.2m per Regenerative Green Oil ("RGO") module sold and allows for non-exclusive sales agency rights in other countries.

Additionally, Sabien's associate company, b.grn, extended its supply contract with COF for the first Regenerative Green Oil recycling plant outside of Korea by another three years. This extension will facilitate b.grn's progress in waste plastic recycling, with advanced due diligence on selecting a specific site location in the US. Identified UK sites are pending the completion of COF's first production plant in Korea, expected in late 2024, which is essential for securing project finance.

Executive Chairman's Comments

Richard Parris, Executive Chairman, commented:

"The M2G business has achieved significant progress in the year to June 2024, despite the last-minute delay of an expected large recurring order into the next period. Our go-to-market model has been transformed by supply contracts with major property management companies and new prestigious customers validating the M2G proposition. We have streamlined the cost structure of the M2G Team and the technology platform for future success.

The extension of our agreement with COF until June 2029 strengthens Sabien's transition to a Green Aggregation business. We look forward to b.grn building and operating the first COF RGO plant outside of Korea following COF's completion of their domestic plant later this year.

In a show of confidence and commitment to the business, I have pledged £300,000 of non-equity funding from my family office to ensure Sabien has sufficient working capital for the next 12 months without the need for a placement. Details will be finalized in consultation with independent directors and the Company's NOMAD."

The Group anticipates announcing its results for the year ended June 30, 2024, in November 2024.

 

For Further Information:

Sabien Technology Group plc

Richard Parris, Executive Chairman

 

 

 

+44 20 7993 3700

investors@sabien.com 

Allenby Capital Limited (Nominated Adviser)

John Depasquale / Nick Harriss / Vivek Bhardwaj 

 

 

+44 203 328 5656

 

Peterhouse Capital Limited (Broker)

Duncan Vasey / Lucy Williams 

 

 

+44 207 469 0930

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTFIFLDDFITIIS
Date   Source Headline
11th Jun 20267:00 amRNSIssue of shares to directors & broker
2nd Jun 20267:00 amRNSProposed balance sheet strengthening & M2G update
29th May 20265:00 pmRNSTotal Voting Rights
21st May 20267:00 amRNSProposed Commercial Partnership & Investment
20th May 20266:22 pmRNSSettlement of Historical Contract
31st Mar 20267:00 amRNSHalf-year Report for the 6 months to 31 Dec 2025
10th Feb 20267:00 amRNSDirector/PDMR Shareholding
16th Jan 20265:30 pmRNSHolding(s) in Company
22nd Dec 202512:02 pmRNSUpdate on Funding and Strategic Arrangements
22nd Dec 202512:02 pmRNSUpdate on Funding and Strategic Arrangements
9th Dec 20251:20 pmRNSResult of Annual General Meeting
9th Dec 20257:00 amRNSAGM Statement & Trading Update
19th Nov 20257:00 amRNSProposed Strategic Agreement with COF
13th Nov 20257:00 amRNSFinal Results for the Year Ended 30 June 2025
10th Nov 20257:00 amRNSNew Factoring Facility
5th Nov 202512:01 pmRNSAppointment of Corporate Broker
2nd Oct 202512:06 pmRNSFurther update on Sabien, b.grn & related matters
19th Sep 20257:00 amRNSTrading Update
31st Jul 20254:59 pmRNSTotal Voting Rights
8th Jul 20257:00 amRNSYear End Trading Update
30th Jun 20252:53 pmRNSIssue of shares to directors
23rd Jun 20254:28 pmRNSHolding(s) in Company
17th Mar 20257:00 amRNSHalf-year Report for the 6 months to 31 Dec 2024
6th Feb 202511:43 amRNSUpdate in relation to Aeristech Limited
27th Jan 20257:00 amRNSTrading update - acceleration of new M2G orders
31st Dec 202412:30 pmRNSTotal Voting Rights
19th Dec 202410:51 amRNSResult of Annual General Meeting
19th Dec 20247:00 amRNSUpdate on US Waste Plastics to Oil Project
28th Nov 20247:00 amRNSDirector/PDMR Shareholding
19th Nov 20247:00 amRNSIssue of shares to non-executive directors
18th Nov 20247:00 amRNSFinal Results & Annual Report & Accounts for 2024
11th Nov 20247:00 amRNSNew M2G Cloud Connection System Order
17th Oct 20247:00 amRNSUpdate on US Waste Plastics to Oil Project
30th Sep 20245:00 pmRNSTotal Voting Rights
26th Sep 20244:21 pmRNSDirector/PDMR Shareholding
19th Sep 20241:00 pmRNSHolding(s) in Company
4th Sep 20245:30 pmRNSAdmission of New Shares & Total Voting Rights
29th Aug 20244:00 pmRNSUpdate on Admission of New Ordinary Shares
20th Aug 20247:00 amRNSRelated Party Funding
8th Jul 20248:15 amRNSTrading Statement
28th Mar 20242:30 pmRNSDirector/PDMR Shareholding
8th Mar 20247:00 amRNSHolding(s) in Company
6th Mar 20247:00 amRNSHolding(s) in Company
5th Mar 202411:52 amRNSHolding(s) in Company
29th Feb 20245:00 pmRNSTotal Voting Rights
21st Feb 202411:27 amRNSResult of Broker Option, Issue of Equity and TVR
20th Feb 20243:45 pmRNSDirector/PDMR Shareholding
19th Feb 20247:45 amRNSPlacement and Broker Option
19th Feb 20247:30 amRNSHalf-year Report for the 6 months to 31 Dec 2023
7th Feb 20247:00 amRNSNew system installed at Hampton Court Palace

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.